{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:21:51Z","timestamp":1782915711778,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"DOI":"10.7759\/cureus.92995","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:31:08Z","timestamp":1758619868000},"source":"Crossref","is-referenced-by-count":1,"title":["Removal of Prostate Calcifications Prior to TULSA-PRO With the Aid of Real-Time Ultrasound Imaging: Our Technique and Experience"],"prefix":"10.7759","author":[{"given":"Kyle","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001362","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer: 12-month outcomes from the pivotal TACT trial","volume":"205","author":"Klotz L","year":"2021","unstructured":"Klotz L, Pavlovich CP, Chin J, et al.. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer: 12-month outcomes from the pivotal TACT trial. J Urol. 2021, 205:769-79. 10.1097\/JU.0000000000001362","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15268","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study","volume":"127","author":"Nair SM","year":"2021","unstructured":"Nair SM, Hatiboglu G, Relle J, et al.. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study. BJU Int. 2021, 127:544-52. 10.1111\/bju.15268","journal-title":"BJU Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/JU9.0000000000000034","article-title":"Durability of functional outcomes after MRI-guided transurethral ultrasound ablation of the prostate: 5-year follow-up","volume":"1","author":"Hatiboglu G","year":"2023","unstructured":"Hatiboglu G, Nair S, Relle J, et al.. Durability of functional outcomes after MRI-guided transurethral ultrasound ablation of the prostate: 5-year follow-up. JU Open Plus. 2023, 1:e00035. 10.1097\/JU9.0000000000000034","journal-title":"JU Open Plus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/end.2021.0866","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer: a systematic review","volume":"36","author":"Dora C","year":"2022","unstructured":"Dora C, Clarke GM, Frey G, Sella D. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer: a systematic review. J Endourol. 2022, 36:841-54. 10.1089\/end.2021.0866","journal-title":"J Endourol"},{"key":"ref5","unstructured":"Profound Medical Inc. TULSA-PRO Instructions for Use. (2024). Accessed. September 1, 2025: https:\/\/profoundmedical.com\/manuals-tulsa-operators-manual\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mp.13183","article-title":"Transurethral ultrasound therapy of the prostate in the presence of calcifications: a simulation study","volume":"45","author":"Suomi V","year":"2018","unstructured":"Suomi V, Treeby B, Jaros J, et al.. Transurethral ultrasound therapy of the prostate in the presence of calcifications: a simulation study. Med Phys. 2018, 45:4793-805. 10.1002\/mp.13183","journal-title":"Med Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01306-6","article-title":"First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study","volume":"23","author":"Peters I","year":"2023","unstructured":"Peters I, Hensen B, Glandorf J, et al.. First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. BMC Urol. 2023, 23:142. 10.1186\/s12894-023-01306-6","journal-title":"BMC Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_41_17","article-title":"The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects","volume":"20","author":"Tang Z","year":"2018","unstructured":"Tang Z, Wu XM, Wei Q, Wu LN. The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects. Asian J Androl. 2018, 20:417-9. 10.4103\/aja.aja_41_17","journal-title":"Asian J Androl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.17018","article-title":"Clinical significance of prostatic calculi: a review","volume":"36","author":"Hyun JS","year":"2018","unstructured":"Hyun JS. Clinical significance of prostatic calculi: a review. World J Mens Health. 2018, 36:15-21. 10.5534\/wjmh.17018","journal-title":"World J Mens Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2014.01.006","article-title":"Detection of prostate calcification with megavoltage helical CT","volume":"21","author":"Hama Y","year":"2014","unstructured":"Hama Y. Detection of prostate calcification with megavoltage helical CT. Acad Radiol. 2014, 21:565-8. 10.1016\/j.acra.2014.01.006","journal-title":"Acad Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2020.10.007","article-title":"Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results","volume":"22","author":"Anttinen M","year":"2020","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Viitala A, et al.. Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results. Eur Urol Open Sci. 2020, 22:79-87. 10.1016\/j.euros.2020.10.007","journal-title":"Eur Urol Open Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.029","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial","volume":"70","author":"Chin JL","year":"2016","unstructured":"Chin JL, Billia M, Relle J, et al.. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol. 2016, 70:447-55. 10.1016\/j.eururo.2015.12.029","journal-title":"Eur Urol"},{"key":"ref13","unstructured":"Pivotal study of MRI-guided transurethral ultrasound ablation in localized prostate cancer (TACT). (2025). Accessed. April 10, 2025: https:\/\/clinicaltrials.gov\/study\/NCT02766543."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415504-removal-of-prostate-calcifications-prior-to-tulsa-pro-with-the-aid-of-real-time-ultrasound-imaging-our-technique-and-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:31:10Z","timestamp":1758619870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415504-removal-of-prostate-calcifications-prior-to-tulsa-pro-with-the-aid-of-real-time-ultrasound-imaging-our-technique-and-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.92995","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}